As new technologies power the drive to achieve personalised health care, doctors may find it difficult to keep up with the pace of discovery. However, a recent collaboration between FDNA and the Manchester Centre for Genomic Medicine could soon change this.
Data is at the heart of applicable genomics. As the volume and depth of genomic data grows, bioinformaticians are translating the data into interpretable patterns leading to new biological insight.
Scientists have successfully mapped how genes are expressed differently in the brains of people with one of five major psychiatric disorders, providing a much needed deeper insight into how our genes influence our risk of developed mental illness, for the first time.
The GA4GH roadmap outlines the first set of standards and frameworks to be launched under GA4GH Connect—a new phase of the organization focused on aligning with the needs of the real-world genomic data sharing community.
SOPHiA GENETICS has unveiled the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The standardized molecular diagnostic application represents a breakthrough in diagnostics for hematological diseases.
“I’d Like to See Our Understanding of at Least One More Disease Transformed by Genomics and Big Data” – Jeremy Grushcow
Combining over 15 years’ experience with pharma and life sciences businesses with a passion for participant-centric research, Jeremy Grushcow is CBO at Sequence Bio, where he saw a once-in-in a lifetime opportunity to change how we treat, prevent and understand disease.
Google’s DeepMind has potentially made the first significant application of Artificial Intelligence (A.I.) in healthcare, after developing AI to diagnose disease by analysing medical images.
Storing data in DNA is a lot easier than getting it back out, but a team of researchers has designed a system that could solve all these problems.
We attended ‘The Great Genome Sequencing Debate’ earlier this week, chaired by Vivienne Parry from Genomics England, to discuss the future of genomic testing.
To help you plan your visit, or perhaps inspire you to sign up for your free place, we’ve put together a handy guide to this year’s theme, and some of our top picks from the agenda.
Paul focuses on the possibilities for big data in biomedicine, using computationally intensive approaches, including deep learning and graph databases.
SOPHiA GENETICS announced at the Precision Medicine World Conference (PMWC) in Silicon Valley that its artificial intelligence, SOPHiA, has gained radiomics capabilities.